Acetylcysteine Injection, Solution
Product Images NDC 63323-963

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Acetylcysteine (NDC 63323-963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Prx Ctnpdp (Prxaceinjctnpdp)

Prx Ctnpdp (Prxaceinjctnpdp)
This is a description of Acetylcysteine injection in 4x30mL single dose vials with NDC code 63323-963-44 and PRX963030. The solution contains 6 grams of Acetylcysteine per 30mL with 200mg per mL concentration that must be further diluted before intravenous use. The unused portion should be discarded. The size of the un varnish area is 50x30 mm. This product is from PREMIERProRX®.*
FDA Label Image

Prxvialpdp (Prxaceinjvialpdp)

Prxvialpdp (Prxaceinjvialpdp)
This is a medication called Acetylcysteine, available as an injectable solution in a 6 grams per 30 mL concentration with 200 mg per mL. The medication must be further diluted before using intravenously, as mentioned on the label. The product is available in a 30 mL single-dose vial intended for prescription use only. The manufacturer is Premier ProRx ®.*
FDA Label Image
FDA Label Image

Figure 1 (Acetylcysteine 01)

FDA Label Image

Figure 2 (Acetylcysteine 02)

Figure 2 (Acetylcysteine 02)
This text appears to be a set of medical instructions related to the ingestion of acetaminophen. It recommends that a serum be drawn for acetaminophen level testing within 24 hours of an overdose, and that acetylcysteine should be considered as a treatment option. The text also includes instructions on plotting plasma level and treatment lines. If the time of ingestion is unknown or unreliable, it suggests considering empiric initiation of acetylcysteine.*
FDA Label Image

Figure 3 (Acetylcysteine 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.